✦ LIBER ✦

DOES TYPE OF BARE METAL OR DRUG ELUTING STENTS, CLINICAL AND BIOCHEMICAL MARKERS OF ATHEROTHROMBOSIS ATTENUATE THE EFFECT OF ANTIPLATELETS

✍ Scribed by Can, M.M.; Tanboga, I.H.; Akgun, T.; Turkyilmaz, E.; Tokgoz, H.C.; Keles, N.; Koca, F.; Ozkan, A.; Karabay, C.Y.; Bezgin, T.; Dogan, C.; Omaygenc, O.; Yaymaci, B.; Sonmez, K.; Saglam, M.; Bitigen, A.; Ozdemir, N.; Kaymaz, C.

Book ID: 118636428
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 71 KB
Volume: 9
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(08)70585-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AS-183: A Comparison of Long-Term Mortal

AS-183: A Comparison of Long-Term Mortality and Stent Thrombosis after Drug-Eluting or Bare-Metal Stent Implantation in Routine Clinical Practice: Updated 4-Year Results from the Asan Medical Center Registry

✍ Duk-Woo Park; Won-Jang Kim; Jong-Young Lee; Jeong-Sook Seo; Sun Yang Min; Sung-H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB